According to Dr. Patricia K. Coyle, the nature of unmanaged multiple sclerosis (MS) produces recurrent attacks on the brain and spinal cord, which results in focal inflammatory lesions that can be visualized with magnetic resonance imaging (MRI). Unfortunately, 80-90% of lesions that form are silent and cannot be detected on the neurological examination, which exposes patients to a greater burden of disease and an increased risk of dysfunction. Furthermore, depending on which neurological components are affected, patients are at heightened risk for a broad suite of deficits, including weakness, spasticity, sensory loss, and cognitive issues. As the disease progresses, symptomatology may include bladder disruption, walking abnormalities, tremor, and fatigue.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More
Culture Key to Data Collection of Sexual Orientation and Gender Identity in Cancer Care
June 23rd 2025This research highlights the key factors, like leadership buy-in, mandatory protocols, and electronic health record workflows, that influence the effective collection of data on sexual orientation and gender identity in outpatient oncology clinics to improve patient-centered care.
Read More